We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

32 hedge funds and large institutions have $6.36M invested in SQZ Biotechnologies Company in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less funds holding

Funds holding: 36 → 32 (-4)

32% less capital invested

Capital invested by funds: $9.35M → $6.36M (-$2.99M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
8
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$218K
2
Millennium Management
Millennium Management
New York
+$77.7K
3
TSS
Two Sigma Securities
New York
+$26.6K
4
SG Americas Securities
SG Americas Securities
New York
+$20.2K
5
VF
Virtu Financial
New York
+$12.6K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$985K
2
Stifel Financial
Stifel Financial
Missouri
-$119K
3
E
Ergoteles
New York
-$47.5K
4
RC
RBF Capital
California
-$39.2K
5
Jane Street
Jane Street
New York
-$31.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$1.54M – – –
AIG
2
American International Group
New York
$1.41M – – –
AG
3
Artal Group
Luxembourg
$900K – – –
MC
4
Maverick Capital
Texas
$589K -$12.1K -16,384 -2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$527K – – –
Stifel Financial
6
Stifel Financial
Missouri
$490K -$119K -161,232 -16%
LCM
7
Laurion Capital Management
New York
$242K – – –
Morgan Stanley
8
Morgan Stanley
New York
$168K +$218K +296,460 +9,049%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$75.8K – – –
BlackRock
10
BlackRock
New York
$68.8K +$455 +618 +0.5%
Millennium Management
11
Millennium Management
New York
$59K +$77.7K +105,546 New
Renaissance Technologies
12
Renaissance Technologies
New York
$42K -$29.3K -39,725 -35%
RC
13
RBF Capital
California
$41.8K -$39.2K -53,256 -42%
BCM
14
Bridgeway Capital Management
Texas
$36.8K – – –
State Street
15
State Street
Massachusetts
$31.4K – – –
SCA
16
Sandy Cove Advisors
Massachusetts
$29K – – –
SG Americas Securities
17
SG Americas Securities
New York
$24K +$20.2K +27,423 +171%
TSS
18
Two Sigma Securities
New York
$20.2K +$26.6K +36,069 New
Northern Trust
19
Northern Trust
Illinois
$17.4K – – –
VF
20
Virtu Financial
New York
$10K +$12.6K +17,075 New
Goldman Sachs
21
Goldman Sachs
New York
$8.34K -$2.44K -3,316 -18%
HSBC Holdings
22
HSBC Holdings
United Kingdom
$6.52K – – –
BSB
23
Bangor Savings Bank
Maine
$6.36K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$4K -$2.7K -3,660 -36%
BAM
25
Baldrige Asset Management
Pennsylvania
$3K – – –
1
2

SQZ Hedge Fund Activity: Q1 2023 in Review

32 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q1 2023, worth a combined $6.36M — down 32% from $9.35M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of SQZ and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Morgan Stanley, adding an estimated $218K. The largest seller was 683 Capital Management, exiting entirely with an estimated $985K sold.

  • 32 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q1 2023, down from 36 in Q4 2022.
  • Funds reported $6.36M of SQZ Biotechnologies Company stock for Q1 2023, down 32% quarter-over-quarter.
  • 4 funds opened new SQZ Biotechnologies Company positions in Q1 2023 and 8 closed out, a net change of -4 holders.
  • The largest SQZ Biotechnologies Company buyer in Q1 2023 was Morgan Stanley, an estimated $218K added.
  • The largest SQZ Biotechnologies Company seller in Q1 2023 was 683 Capital Management, an estimated $985K sold.

Based on aggregated 13F filings for Q1 2023.